Further studies have shown that the truncated variants of ATM and CHEK2 are more closely associated with estrogen receptor (ER)-positive BC, while BARD1, BRCA1, BRCA2, PALB2, RAD51C, and RAD51D are more closely related to ER-negative BC (29). This evidence concerns the gene RAD51D and breast cancer.